AI News 180m Report

2026-09-14 21:00–24:00 JST

118 received, 118 listed, 5 sources ・ Page 2 of 2

One place for news and notices from 2 countries/regions: Taiwan, 93 items from 4 sources; Japan, 25 items from 1 source.

One edition every 180 minutes: every item from every source received in the period, with the original link.

Taiwan | 鉅亨網 (continued)(22)

Hard to pick stocks amid high-level volatility! Foreign investors snap up actively managed ETFs over the past month, with 00403A and 00988A leading

Published ・ Source Taiwan | 鉅亨網

Taiwan stocks have been volatile at elevated levels, with trading volume shrinking. Foreign investors made heavy net purchases of actively managed ETFs over the past month, with 統一投信’s 00403A and 00988A taking the top spots. This reflects institutional investors’ endorsement of active management strategies and carries market-signaling significance.

Companies mentioned:統一投信、復華投信、凱基投信、群益投信、野村投信、中信投信

Active stock picking scores amid volatile high-level trading! 00404A forecasts a 0.36-yuan distribution; buy tomorrow for a last chance to get in

Published ・ Source Taiwan | 鉅亨網

AB Taiwan Momentum Income 50 Active ETF (00404A) will make its first distribution since its launch, paying 0.36 yuan per unit. It will go ex-dividend on September 16, and tomorrow is the last day to buy. The ETF uses active stock selection and diversified industry allocations to address Taiwan’s volatile, high-level market and industry rotation, emphasizing both income and resilience.

Companies mentioned:聯博投信

Shareholders rush to subscribe! iPASS’s 300 million-yuan capital increase is oversubscribed, payment deadline extended to 12/15

Published ・ Source Taiwan | 鉅亨網

一卡通票證公司 extended the payment deadline for its 300 million yen capital increase due to oversubscription. The deadline was extended to December 15, 2026, amid strong subscription interest from major shareholders. iPASS MONEY has surpassed 7.25 million users and is aiming to turn profitable in 2027.

Companies mentioned:一卡通票證公司

Is Powell striking a hawkish tone? Markets have priced in expectations of 3 rate hikes; Fidelity says actual Fed hikes may fall short of forecasts

Published ・ Source Taiwan | 鉅亨網

富達國際 analyzed expectations for interest rate hikes by the 聯準會, noting that markets have priced in expectations of 3 hikes, but the actual number may be lower. It offered recommendations on bond market allocation strategies.

Companies mentioned:聯準會、富達國際

Shares soar nearly 400%, then the company presses its advantage! Kioxia reportedly plans U.S. listing next year, seeking to raise at least US$10 billion

Published ・ Source Taiwan | 鉅亨網

Japanese memory maker Kioxia is considering a U.S. ADR listing amid the AI investment boom. It aims to raise more than $10 billion to boost liquidity and attract U.S. investors.

Companies mentioned:アメリカ銀行、高盛、モルガン・スタンレー、SKハイニクス

No decision-making process required: Trump announces 10% tariff on Irish whiskey will be scrapped

Published ・ Source Taiwan | 鉅亨網

U.S. President Donald Trump announced the removal of a 10% tariff on Irish whiskey. The industry welcomed the move and expects it to benefit the economy.

Original〈台幣〉一度重貶逾1角 觀望超級央行周量縮收31.688元

Published ・ Source Taiwan | 鉅亨網

The New Taiwan dollar temporarily fell by 1.41 jiao, closing at 31.688 yuan. Central bank intervention and a wait-and-see market stance influenced the move. Markets remained cautious ahead of policy announcements from the U.S. Federal Reserve and the Bank of Japan.

Companies mentioned:聯準會、日本銀行、英國央行、聯電、鴻海

Is it worthwhile to pay inheritance tax with stocks? Will the allowable amount be discounted if share prices fall? Tax bureau explains how to understand market fluctuations and save on taxes

Published ・ Source Taiwan | 鉅亨網

Taiwan’s tax authorities announced details of a system for paying estate taxes with listed shares. Because share price movements can affect whether the full amount or only part of the tax can be paid in shares, the timing of an application is important.

Executives warn that rapid development threatens humanity; AI concept stocks plunge in response

Published ・ Source Taiwan | 鉅亨網

Executives at several AI companies warned that rapid technological advances could endanger humanity, prompting a market reaction and steep declines in AI-related stocks.

Companies mentioned:Anthropic、OpenAI、xAI、SoftBank、Kioxia、Tokyo Electron、TSMC、SK Hynix、Samsung Electronics、Sony Financial Group、Saxo Bank、T. Rowe Price

Taiwan | 環球生技月刊(9)

2026-09-14 Institutional investor activity: (net buys) 高端疫苗 696 lots, 藥華藥 526 lots, 台康生技 260 lots; (net sells) 北極星藥業-KY 833 lots, 葡萄王 511 lots, 康霈 403 lots - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Companies mentioned:高端疫苗、藥華藥、台康生技、北極星藥業-KY、葡萄王、康霈

2026-09-14 Biotech stocks: (gainers) 睿生光電 9.79%, 台康生技 6.07%, 沛爾生醫-創 5.28%; (decliners) 浩宇生醫 9.46%, 華廣 7.53%, 藥華藥 7.03% - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Companies mentioned:睿生光電、台康生技、沛爾生醫、浩宇生醫、華廣、藥華藥

09/14 Biotech Stock Moves - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Facts

  • September 17, 115
  • 505(b)(2) new drug AX251
  • 睿生光電 9.79%
  • 台康生技 6.07%
  • 沛爾生醫 5.28%
  • 浩宇生醫 9.46%
  • 華廣 7.53%

Companies mentioned:精華生醫、瑩碩、康霈、睿生光電、台康生技、沛爾生醫、浩宇生醫、華廣、藥華藥

久裕 (4173) to hold an online investor conference on 9/15 at the invitation of 統一證券 - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Facts

  • Date of occurrence: 115/09/15

Companies mentioned:久裕、統一證券

曜亞 (4138) to hold an investor conference on 9/15 at the invitation of 統一證券 - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Facts

  • OTC-listed company) 4138 曜亞
  • Date of occurrence: 115/09/15

Companies mentioned:曜亞、統一證券

佳醫 (4104) to hold an investor conference on 9/15 at the invitation of 統一證券 - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Facts

  • Date of occurrence: 115/09/15

Companies mentioned:佳醫、統一證券

康霈 (6919): FDA completed its 30-day IND review of the trial amendment application for CBL-0302, the pivotal Phase 3 clinical trial of its weight-loss drug CBL-514 - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Facts

  • FDA IND 30-day review period

Companies mentioned:康霈、FDA

麗豐-KY (4137) subsidiary and others resolve to distribute cash dividends - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Companies mentioned:麗豐-KY、HongKongChlitinaInternationalLimited、ChlitinaInternationalLimited

09/14 Biotech Stock Moves - Global Bio & Investment

Published ・ Source Taiwan | 環球生技月刊

Summary not yet available

Facts

  • September 17, 115
  • 505(b)(2) new drug AX251
  • 睿生光電 9.79%
  • 台康生技 6.07%
  • 沛爾生醫 5.28%
  • 浩宇生醫 9.46%
  • 華廣 7.53%

Companies mentioned:精華生醫、瑩碩、康霈、睿生光電、台康生技、沛爾生醫、浩宇生醫、華廣、藥華藥

Other formats:JSONMarkdownRSS